Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific open surgery instrument market was negatively impacted by the COVID-19 pandemic, resulting in declines in procedure volumes, units sold, and overall market value in 2020. However, the market has been recovering strongly and will exhibit moderate growth over the forecast period, fueled mainly by an expanding patient pool, attributable to an aging population and rising disease prevalence, and thus rising procedure volumes.

This Medtech 360 Report provides high-level market metrics for open surgery instruments in Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific from 2019 through 2031.

Table of contents


Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Video and High-Tech Hardware Devices – Market Insights – United States
The US video and high-tech hardware device market will experience modest expansion through 2035. This growth is primarily driven by the increasing adoption of articulated surgical robotic systems…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…